Effect of borderline glucose intolerance on fetal maternal outcome
Tarih
2017Yazar
Tokgozoglu, N.
Kahramanoglu, I.
Sal, V.
Turan, H.
Namazov, A.
Erdogdu, E.
Cakar, E.
Üst veri
Tüm öğe kaydını gösterÖzet
Purpose of investigation: The aim of this study was to compare the maternal and neonatal adverse outcomes in pregnant women whose glucose challenge test (GCT) results were below 130 mg/dl and between 130-139 mg/dl. Materials and Methods: Three hundred and six women with 50-gram GCT results of 130-139 mg/dl and 305 women with 50-gram GCT results of < 130 mg/dl were recruited. Results: Higher pre-postpartum hemoglobin difference (p = 0.001), longer postpartum hospitalisation time (p = 0.001), and increased cesarean section rates (p = 0.01) were reported in the study group. There were no differences between two groups in rates of preeclampsia, polyhydramnios, ablatio placenta, and chorioamnionitis. Conclusions: The authors suggest that a GCT result between 130-139 mg/dl is not associated with higher maternal and neonatal morbidity. Results do not support a conclusion of high maternal and neonatal morbidity in the study group and give an impression that the 140 mg/dl threshold value is adequate for screening.
Koleksiyonlar
- Makale [92796]